These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2899329

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
    Fischer-Cornelssen KA.
    Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092
    [No Abstract] [Full Text] [Related]

  • 7. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M, Wendt G, Binz U, Steiner B, Hole G.
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [Abstract] [Full Text] [Related]

  • 8. Treatment of anxiety with ketazolam in elderly patients.
    Bresolin N, Monza G, Scarpini E, Scarlato G, Straneo G, Martinazzoli A, Benincà G, Cattoni C, De Candia R, Belloni G.
    Clin Ther; 1988 Jul; 10(5):536-42. PubMed ID: 2908803
    [Abstract] [Full Text] [Related]

  • 9. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M, Laakmann G, Dieterle D, Blaschke D.
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
    Pecknold JC, Familamiri P, McClure DJ, Elie R, Chang H.
    J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE, Ahles S, Halaris A, DeMet E, Hill MA.
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
    Szegedi A, Wetzel H, Angersbach D, Dunbar GC, Schwarze H, Philipp M, Benkert O.
    Pharmacopsychiatry; 1997 May; 30(3):97-105. PubMed ID: 9211571
    [Abstract] [Full Text] [Related]

  • 15. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD.
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [Abstract] [Full Text] [Related]

  • 16. Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndrome.
    Laakmann G, Blaschke D, Hippius H, Schewe S.
    Pharmacopsychiatry; 1989 May; 22(3):120-5. PubMed ID: 2568645
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M, Zbytovský J, Kudrnová K.
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.